Jim C. Hu, M.D., M.P.H. discusses the challenges of accurate risk stratification, explains the benefits of targeted prostate biopsy, and looks at several studies that followed men on active surveillance.
Feature content:
No
Jim C. Hu, M.D., M.P.H. discusses the challenges of accurate risk stratification, explains the benefits of targeted prostate biopsy, and looks at several studies that followed men on active surveillance.
© 2016 Weill Cornell Medicine All rights reserved.